Patents by Inventor Harold A. Nash

Harold A. Nash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6126958
    Abstract: Disclosed is a vaginal ring intended for the release of at least one drug over a prolonged time period. The vaginal ring contains a ring body made of a first polymeric material having at least one hollow internal channel defining an opening to the exterior of said body and which channel is adapted to receive a drug-containing core through said opening, and an intravaginally administerable drug-containing core disposed in the channel. The core is positioned in the vaginal ring body suitably prior to use in order to substantially avoid initial bursts of drug into the tissues of the subject and resultant side effects such as nausea and vomiting. The core contains a pharmaceutically effective amount of at least one intravaginally administerable drug dispersed in a second polymeric material. The first and second polymeric materials may be the same or different. Representative drugs include contraceptive agents and other steroidal substances for use in hormone replacement therapy.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: October 3, 2000
    Assignee: The Population Council, Inc.
    Inventors: Saleh Ismail Saleh, Harold A. Nash, C. Wayne Bardin, Troy Harmon
  • Patent number: 5972372
    Abstract: Disclosed is a vaginal ring intended for the release of at least one drug over a prolonged time period. The vaginal ring contains a ring body made of a first polymeric material having at least one hollow internal channel defining an opening to the exterior of the ring body and which channel is adapted to receive a, drug-containing core through the opening, and an intravaginally administerable drug-containing core disposed in the channel. The core is positioned in the vaginal ring body suitably prior to use in order to substantially avoid initial bursts of drug into the tissues of the subject and resultant side effects such as nausea and vomiting. The core contains a pharmaceutically effective amount of at least one intravaginally administerable drug dispersed in a second polymeric material. The first and second polymeric materials may be the same or different. Representative drugs include contraceptive agents and other steroidal substances for use in hormone replacement therapy.
    Type: Grant
    Filed: May 2, 1997
    Date of Patent: October 26, 1999
    Assignee: The Population Council, Inc.
    Inventors: Saleh Ismail Saleh, Harold A. Nash, C. Wayne Bardin, Troy Harmon
  • Patent number: 4292965
    Abstract: This invention relates to an improved intravaginal ring for use as a contraceptive comprising an inert elastomer core, a medicated layer encircling the core and an outer inert elastomer layer and method of manufacturing the intravaginal ring.
    Type: Grant
    Filed: December 29, 1978
    Date of Patent: October 6, 1981
    Assignee: The Population Council, Inc.
    Inventors: Harold A. Nash, Daniel R. Mishell, Jr.